Elevance Health, Inc. (NYSE:ELV – Get Free Report) declared a quarterly dividend on Tuesday, July 14th. Investors of record on Thursday, September 10th will be given a dividend of 1.72 per share on Friday, September 25th. This represents a c) annualized dividend and a yield of 1.8%. The ex-dividend date of this dividend is Thursday, September 10th.
Elevance Health has raised its dividend payment by an average of 0.1%annually over the last three years and has increased its dividend annually for the last 14 consecutive years. Elevance Health has a payout ratio of 17.5% indicating that its dividend is sufficiently covered by earnings. Analysts expect Elevance Health to earn $29.11 per share next year, which means the company should continue to be able to cover its $6.88 annual dividend with an expected future payout ratio of 23.6%.
Elevance Health Trading Down 8.7%
Elevance Health stock traded down $36.94 during midday trading on Wednesday, reaching $389.85. 3,896,777 shares of the stock traded hands, compared to its average volume of 1,819,670. The firm has a market cap of $84.66 billion, a PE ratio of 16.58, a price-to-earnings-growth ratio of 2.41 and a beta of 0.67. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.70. The company has a 50-day simple moving average of $399.37 and a two-hundred day simple moving average of $354.74. Elevance Health has a 12-month low of $273.71 and a 12-month high of $436.24.
About Elevance Health
Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.
Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.
Further Reading
- Five stocks we like better than Elevance Health
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.
